Mild Essential Hypertension Completed Phase 2 Trials for CYT006-AngQb (DB05739)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0036953 (Mild Essential Hypertension) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00710372 | Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension | Treatment |